Brief: Xspray Posts Q4 Adj. EPS Loss of SEK 2.48

Xspray Pharma publ AB

15/02/2023 07:13

Feb 15 (Reuters) - Xspray Q4 adjusted free cash flow SEK -35.003 million.
* Q4 pretax profit SEK -55.22 million
* Q4 revenue SEK 0